The $1 Psychedelic Stock No One Is Talking About
Earlier today Eli Lilly was granted FDA breakthrough status for its Alzheimer’s drug. Shares of the stock soared by 7.3% off the news. And it also caused a “sympathy effect” In other words, other companies working on Alzheimer’s treatments also…
Read More Now What You Didn’t Know About VWAP
As you’re well aware, technical analysis tools are abundant and come in all shapes and sizes. I, for one, am a big fan of Fibonaccis and Moving Averages – they make sense for my strategies. In addition, they would often…
Read More Now Return of the SPAC
Before I jump in and share the three SPACs I’m eyeing to play on the long side…allow me to give you some background information of what’s happened in the space over the last few months. Late 2020 to the first…
Read More Now 
